1Dustan HP.Does Keloid pathogenesis hold the key to understanding bl-ack/white differences in hypertension severity[J]? Hypertension,1995,26(6):858-862
1Siemp AE, Kirschner RE. Keloids and scars;A review of keloids and scars,their pathogenesis, risk factors, and management [ J]. Current Opinion in Pediatrics,2006,1 8(4) :396-402.
2Robles DT, Moore E, Draznin, et al. Keloids: pathophysiology and management [ J ]. Dermatol Online,2007.13 ( 3 ) :9.
3Mameros AG, Non-is JE, Watanabe S, et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11 [ J]. J Invest Dermatol, 2004,122 ( 5 ) : 1126-1132.
4Maarouf M,Schleicher U, Sehmachtenberg A, et al. Radiotherapy in the management of keloids Clinical experience with electron beam irradiation and comparison with X-ray therapy [ J ]. Strahlenther Onkol, 2002, 178(6) :330-335.
5Bayat AB, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and hypertro -phic scarring:transforming growth factor beta 1 common polymorphisms and plasma levels [ J ] . Plast Reconstr Surg, 2003,111 (2) :535-543.
7Boyadjiev C, Popehristova E, Mazgalova J. Histomorphologic changes in keloids treated ,vitll Kenacort [ J ].J Trauma, 1995,38 (2) :299-302.
8Claude Roques, Luc Teot. The use of corticosteroids to treat keloids [ J ]. The International Journal of Lower Extremity Wounds, 2008,7 (3) : 137-145.
9Teelucksingh S, Balkaran B, Ganeshmoorthi A, et al. Prolonged childhood Cushing' s syndrome secondary to intralesional, triamcinolone acetonide [ J ]. AnnTropPaediatr, 2002,22 ( 1 ) : 89-91.
10Luo S, Benathan M, Rafoul W, et al. Abnormal balance between proliferation an d apoptotic cell death in fibroblasts derived from keloid lesions[ J]. Plast Reconstr Surg,2001,107 ( 1 ) :87-96.
